Fig 1: (A) Percentage of CD4+ T helper lymphocytes expressing TLR2 in patients with endometriosis (EM) and healthy volunteers (HV); (B) Percentage of CD8+ T helper lymphocytes expressing TLR2 in patients with endometriosis (EM) and healthy volunteers (HV); (C) Percentage of CD19+ T helper lymphocytes expressing TLR2 in patients with endometriosis (EM) and healthy volunteers (HV); (D) Percentage of CD4+ T helper lymphocytes expressing TLR3 in patients with endometriosis (EM) and healthy volunteers (HV); (E) Percentage of CD8+ T helper lymphocytes expressing TLR3 in patients with endometriosis (EM) and healthy volunteers (HV); (F) Percentage of CD19+ T helper lymphocytes expressing TLR3 in patients with endometriosis (EM) and healthy volunteers (HV); (G) Percentage of CD4+ T helper lymphocytes expressing TLR4 in patients with endometriosis (EM) and healthy volunteers (HV); (H) Percentage of CD8+ T helper lymphocytes expressing TLR4 in patients with endometriosis (EM) and healthy volunteers (HV); (I) Percentage of CD19+ T helper lymphocytes expressing TLR4 in patients with endometriosis (EM) and healthy volunteers (HV); (J) Percentage of CD4+ T helper lymphocytes expressing TLR7 in patients with endometriosis (EM) and healthy volunteers (HV); (K) Percentage of CD8+ T helper lymphocytes expressing TLR7 in patients with endometriosis (EM) and healthy volunteers (HV); (L) Percentage of CD19+ T helper lymphocytes expressing TLR7 in patients with endometriosis (EM) and healthy volunteers (HV); (M) Percentage of CD4+ T helper lymphocytes expressing TLR8 in patients with endometriosis (EM) and healthy volunteers (HV); (N) Percentage of CD8+ T helper lymphocytes expressing TLR8 in patients with endometriosis (EM) and healthy volunteers (HV); (O) Percentage of CD19+ T helper lymphocytes expressing TLR8 in patients with endometriosis (EM) and healthy volunteers (HV); (P) Percentage of CD4+ T helper lymphocytes expressing TLR9 in patients with endometriosis (EM) and healthy volunteers (HV); (Q) Percentage of CD8+ T helper lymphocytes expressing TLR9 in patients with endometriosis (EM) and healthy volunteers (HV); (R) Percentage of CD19+ T helper lymphocytes expressing TLR9 in patients with endometriosis (EM) and healthy volunteers (HV). Data are presented as violin plots, showing the median and distribution of values. In all analyzed subpopulations, a significantly higher percentage of cells positive for a given TLR was found in the group of patients with endometriosis compared to the control group (p < 0.05). The results indicate an increased expression profile of innate immune response receptors in patients with endometriosis. Statistically significant differences are indicated by an asterisk (*).